TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: faster wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: better cosmetic results
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: re-epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean diagnosis time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean OSAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in VAS pain scores at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported mammogram use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Humeral head center distance from glenoid center
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impedance measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of IAN damage
Endpoint domain: Adverse events/effects
Primary endpoint: Median RAST values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean disease activity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of death at 1 and 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Application of participatory approach by supervisors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean Chalder fatigue score reduction
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Whole-gut transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colonic transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of men free from biochemical failure at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thromboembolic events within 3 months of stroke
Endpoint domain: Mortality/survival
Primary endpoint: Haemorrhagic transformation of ischaemic stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality ratio
Endpoint domain: Mortality/survival
Primary endpoint: Difference in survival
Endpoint domain: Mortality/survival
Primary endpoint: Surgical resection rates
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Mean VVA objective symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability (burning and itching)
Endpoint domain: Adverse events/effects
Primary endpoint: psychomotor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rapid information processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective ratings of positive mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Determinants of health-seeking behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Isolation of anaerobic strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gastric ulcer relapses
Endpoint domain: Adverse events/effects
Primary endpoint: rate of infection during pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: Bone serum crosslaps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Composite of safety and efficacy parameters
Endpoint domain: Mortality/survival
Primary endpoint: VAS scores of pain at 44th hour after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dosage of analgesia pump after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cost to patients per visit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean time cost to society per visit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of hemodialysis/hemofiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Diuresis levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: sway area on a foam surface without vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sway variability in the medial-lateral direction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: medication understanding and use self-efficacy scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Control rate of asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in inhaled corticosteroid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left ventricular end-diastolic volume decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Atrial and pulmonary artery pressures fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Contractility increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Objective measurable responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fracture-healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: function-recovering time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: detection rate for prospective memory targets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of respiratory tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Psychotic exacerbations
Endpoint domain: Adverse events/effects
Primary endpoint: Diabetes diagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Small for gestational age birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Neonatal composite morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved functioning per LLFDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowered mood symptoms per HSCL‐25
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decreased disability days per WHODAS 2.0
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: maximum concentration of EPA, DHA, and EPA+DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the concentration-time curve from 0 to 72 h for EPA, DHA, and EPA+DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SB index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Snoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HA intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV(1)AUC(0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: exercise time to exhaustion at 85% VO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolonged 6-month abstinence from alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 30-day prolonged alcohol abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak torque of knee flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total work of knee flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Subtherapeutic nevirapine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 1/2 rash
Endpoint domain: Adverse events/effects
Primary endpoint: Prolongation of ACT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prolongation of APTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in F1 + 2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: very favorable outcomes (modified Rankin score, 0-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functionally independent (modified Rankin score, 0-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free quality-adjusted life-year gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Progression-free life-year gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Additional patient attaining objective response
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Agreement on physical activity recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants active using MVPA in ≥10 min bouts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time of peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in HbA1c from baseline to 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fasting plasma glucose from baseline to 24 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: infants' brain function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of energy intake from fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intensity of physical activity in PE classes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported daily energy intake from fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RT-PCR-confirmed non-influenza respiratory virus infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in serum DKK-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum PINP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of blood loss from placental delivery to the end of LSCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quantity of blood loss from the end of LSCS to 2 hours postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Oxygen cost
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality rate at six months
Endpoint domain: Mortality/survival
Primary endpoint: Fasting proinsulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Impulse purchases of cigarettes
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Number of cigarettes smoked
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: improvement on a prose memory task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: improvement in prospective memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: family report of disinhibition in daily life
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Referral rates to specialists
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean improvement of IIEF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive NPT test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response durability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAD anxiety subscale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: surgical healing results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: enamel loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: reduction in sore throat pain intensity over 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first analgesia requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intensity of chronic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness in treatment of active distal ulcerative colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: appearance of the tympanic membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ear outcomes
Primary endpoint: discomfort levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of chlamydia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of gonorrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of syphilis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of trichomoniasis
Endpoint domain: Adverse events/effects
Primary endpoint: Probability of psychosis relapse
Endpoint domain: Mortality/survival
Primary endpoint: Average annual incremental cost per relapse avoided
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: otolaryngological outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preliminary speech outcomes
Endpoint domain: Life impact
Endpoint subdomain: Communication functioning
Primary endpoint: slope of the hypoxic ventilatory response curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: minute ventilation (VE90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: tidal volume (TV90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: u-NGAL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HIV-specific CD8+ T-cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: granzyme B content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: exhaustion markers expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: changes in body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-risk behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV transmission risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving normal ALT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Percentage of patients achieving undetectable HCV RNA values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Ankle joint stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum midazolam concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excellent first-stage analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Supplementation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of new demineralized lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first-time bracket failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preservation of facial nerve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hearing preservation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lachman test grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day post-PCI coronary events
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative arm sensory disturbance
Endpoint domain: Adverse events/effects
Primary endpoint: D-dimer levels at the end of CPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Allogeneic blood requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Likelihood of becoming negative for HBeAg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of becoming negative for hepatitis B surface antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMI percentile curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WC percentile curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WHtR percentile curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of pin track infections
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal-sprint and countermovement jump performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vigour
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Success rate of nerve blocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-PCI myonecrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of symptoms and signs of dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progressive sperm motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: post-operative upper genital tract infection
Endpoint domain: Adverse events/effects
Primary endpoint: Mean antibiotic charges
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Inadequate intake of four or more nutrients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peak valgus knee moments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Positive and affective symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in high-density lipoprotein (HDL) cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean diurnal IOP at day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall RQLQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ESS score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reduction in new cases of cardiovascular disease (CV disease)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in new cases of coronary heart disease (CHD)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in new cases of myocardial infarctions (MI)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prediction of cancer mortality after radical prostatectomy
Endpoint domain: Mortality/survival
Primary endpoint: Mean health plan costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Inpatient admissions prevalence
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Plasma cobalt concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Red cell cobalt concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Urine cobalt concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cocaine exposure (maximum concentration, area under the curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life of cocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective reports of feeling high
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: postoperative death
Endpoint domain: Mortality/survival
Primary endpoint: IBS-GIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-AR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS-QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: pain in the groin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol-related predatory aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes